GT
39
2
HRL
38
3
DVN
40
-2
DHI
40
3
MSI
47
-2
EXR
26
2
PNW
57
2
C
85
3
MCD
46
4
FTI
61
-2
ALLE
48
2
CMI
73
-2
MTB
75
2
AN
52
2
GWW
65
3
MDLZ
28
4
PM
56
2
CNP
55
3
EXC
53
3
KIM
56
5
GT
39
2
HRL
38
3
DVN
40
-2
DHI
40
3
MSI
47
-2
EXR
26
2
PNW
57
2
C
85
3
MCD
46
4
FTI
61
-2
ALLE
48
2
CMI
73
-2
MTB
75
2
AN
52
2
GWW
65
3
MDLZ
28
4
PM
56
2
CNP
55
3
EXC
53
3
KIM
56
5
Financhill
Back

Palo Alto Networks, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
46

PANW
Palo Alto Networks, Inc.

Last Price:
$187.26
Seasonality Move:
6.11%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
46
Palo Alto Networks, Inc. (PANW) is a Sell

Is Palo Alto Networks, Inc. a Buy, Sell or Hold?

  • The current Palo Alto Networks, Inc. [PANW] share price is $187.22. The Score for PANW is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PANW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PANW Stock Price Chart

What is Palo Alto Networks, Inc.'s stock price today?

  • The Palo Alto Networks, Inc. share price today is $187.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PANW is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

PANW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 49.32 Buy
Relative Strength Index (14 RSI): 41.85 Sell
Chaikin Money Flow: 1085565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (184.9 - 194.2) Sell
Bollinger Bands (100): (183.84 - 211.42) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

PANW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 186.75 Buy
20-day SMA: 190.03 Sell
50-day SMA: 201.12 Sell
200-day SMA: 192.34 Sell
8-day EMA: 145.85 Buy
20-day EMA: 84.45 Buy
50-day EMA: 39.89 Buy
200-day EMA: 10.88 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Palo Alto Networks, Inc. Earnings Growth & PANW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.49 per share, and an increase next year of $0.58 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Palo Alto Networks, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):